Back to homepage

Tag "AstraZeneca"

AstraZeneca to use new vax technology to treat cancer, heart disease

AstraZeneca to use new vax technology to treat cancer, heart disease

🕔08:29, 29.Sep 2021

London, Sep 29  UK drugmaker AstraZeneca has partnered with scientists at Imperial College London to develop a new vaccine technology to treat cancer, heart conditions and other non-infectious diseases and illnesses. The technology was originally intended for targeting Covid-19, and

Read Full Article
Single dose of Pfizer, AstraZeneca can cut Covid transmission by 50%

Single dose of Pfizer, AstraZeneca can cut Covid transmission by 50%

🕔18:04, 28.Apr 2021

London, April 28  A single dose of a Pfizer or AstraZeneca vaccine against coronavirus disease can reduce transmission by up to 50 per cent, finds a study. The study led by UK’s Public Health England (PHE) showed that people who

Read Full Article
AstraZeneca vax highly effective in preventing Covid-19

AstraZeneca vax highly effective in preventing Covid-19

🕔18:50, 23.Nov 2020

New Delhi, Nov 23  AstraZeneca announced Monday that positive high-level results from an interim analysis of clinical trials of the Covid-19 vaccine candidate in the UK and Brazil showed it was highly effective in preventing the disease, the primary endpoint,

Read Full Article
Serum Institute to price Covid vaccine at less than Rs 250/dose

Serum Institute to price Covid vaccine at less than Rs 250/dose

🕔18:05, 7.Aug 2020

New Delhi, Aug 7  The Serum Institute of India would introduce candidate vaccines from AstraZeneca and Novavax for COVID-19 at less than Rs 250 per dose in India. The Pune-based institute would offer up to 100 million doses at a

Read Full Article
WHO says AstraZeneca, Modena leading vaccine race

WHO says AstraZeneca, Modena leading vaccine race

🕔07:51, 27.Jun 2020

Geneva, June 27  After admitting that the world may have a Covid-19 vaccine within one year or even a few months earlier, the World Health Organization (WHO) on Friday said that UK-based AstraZeneca is leading the vaccine race while US-based

Read Full Article